Rockefeller Capital Management
ESPR icon

Rockefeller Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Rockefeller Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.15K Buy
2,611
+1,891
+263% +$5.99K ﹤0.01% 4128
2025
Q4 		$2.66K Buy
+720
New +$2.33K ﹤0.01% 4247
2023
Q1 		– Sell
-200
Closed -$1K – 2558
2022
Q4 		$1K Hold
200
– – ﹤0.01% 3674
2022
Q3 		$1K Hold
200
– – ﹤0.01% 3704
2022
Q2 		$1K Hold
200
– – ﹤0.01% 3940
2022
Q1 		$0 Hold
200
– – ﹤0.01% 3917
2021
Q4 		$1K Hold
200
– – ﹤0.01% 3630
2021
Q3 		$2K Hold
200
– – ﹤0.01% 3425
2021
Q2 		$4K Sell
200
-500
-71% -$12K ﹤0.01% 3080
2021
Q1 		$19K Buy
700
+500
+250% +$14.8K ﹤0.01% 2299
2020
Q4 		$5K Hold
200
– – ﹤0.01% 2424
2020
Q3 		$7K Hold
200
– – ﹤0.01% 2109
2020
Q2 		$10K Hold
200
– – ﹤0.01% 1893
2020
Q1 		$6K Hold
200
– – ﹤0.01% 1888
2019
Q4 		$12K Buy
+200
New +$8.99K ﹤0.01% 1555

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return